Xoma | XOMA - Actif À Court Terme





Actif À Court Terme Changement Date
AbbVie USD 29.06B 523M 2025-12
Agenus USD 133.44M 514K 2025-12
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
Ardelyx USD 382.32M 14.33M 2025-12
aTyr Pharma USD 245.8M 152.79M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Celldex Therapeutics USD 534.66M 69.68M 2025-12
Curis USD 14.42M 10.39M 2025-06
Eli Lilly USD 55.63B 6.44B 2025-12
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Incyte USD 5.02B 746.01M 2025-12
MacroGenics USD 219.94M 12.15M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Novartis USD 30.46B 2.26B 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Prothena USD 315.19M 24.78M 2025-12
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Xoma USD 110.71M 5.78M 2025-09